Lv1
68 积分 2025-01-03 加入
Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy
5小时前
待确认
Pseudoprogression and hyperprogression in lung cancer: a comprehensive review of literature
5小时前
已完结
Pseudoprogression in lung cancer patients treated with immunotherapy
5小时前
已完结
Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients
1个月前
已完结
PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals for the localization pulmonary metastasis in a papillary thyroid tumour patient
1个月前
已完结
EP02.04-005 Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC
1个月前
已完结
ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights
1个月前
已完结
[ALK gene fusion associated non-small cell lung cancer: automated immunostainer detection and clinicopathologic perspectives]
1个月前
已关闭
ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights
1个月前
已完结
Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
1个月前
已完结
皖公网安备34019202002308
